Therachon ag
Webb5 sep. 2024 · U.S. pharmaceutical company Pfizer is acquiring Basel biotech Therachon for US$ 340 million. Additional payments of US$ 470 million may also be received on the achievement of key milestones. Therachon has developed a drug for the treatment of a form of short-limbed dwarfism. Drug discovery (img: motorolka_10/shutterstock) WebbTherachon is a global biotechnology company, focused on developing treatments for rare, genetic diseases that currently have no available treatments. We are committed to the …
Therachon ag
Did you know?
Webb28 mars 2024 · Therachon AG, a clinical-stage biotechnology company focused on rare diseases, announced it has completed a $60 million mezzanine financing led by Novo Holdings and joined by new investors Cowen Healthcare Investments, Pfizer Ventures and funds managed by Tekla Capital Management LLC. Existing investors Versant Ventures, … Webb1 juli 2024 · Pfizer Inc. (NYSE: PFE) today announced the successful completion of its acquisition of the privately held clinical-stage biotechnology company Therachon Holdin
Webb15 maj 2024 · Catalent has signed an agreement with Therachon AG to support development of TA-46 addressing achondroplasia, the most common form of short … WebbAbout Therachon AG Therachon is a global biotechnology company, focused on developing treatments for rare, genetic diseases that currently have no available treatments. We are committed to the community, caregivers and advancing research to transform the lives of people with unmet medical needs.
WebbTherachon is a global biotechnology company focused on developing treatments for serious rare conditions with high unmet medical need. Founded in 2014, Therachon’s … Webb9 aug. 2024 · Therachon AG, a clinical-stage biotechnology company focused on rare diseases, today announced it has completed a $60 million mezzanine financing led
WebbValberedningens förslag och motiverat yttrande till årsstämman 20 23. Valberedningen för Vicore Pharma Holding AB (publ) (“ Bolaget” eller “ Vicore Pharma ”), som utgörs av Jacob Gunterberg (styrelseordförande), Staffan Lindstrand (utsedd …
WebbTHERACHON HOLDING AG THERACHON AG, GLYPHARMA THERAPEUTIC INC., AND SHAREHOLDERS LISTED ON SCHEDULE A SEPTEMBER 30, 2024 TABLE OF CONTENTS … small textile machineWebbPrior to this, he was CEO and co-founder of Therachon AG, which was acquired by Pfizer, Inc. in 2024 for $810 million. Luca previously worked at Roche for 12 years, where he advanced over 20 molecules into the clinic, catalyzed the creation of Synosia and Clementia, two companies built from Roche asset spin-offs, and led multiple in-licensing … highway sand barrelsWebb1 sep. 2024 · Therachon AG, a biotechnology company focused on rare genetic diseases, today announced it has appointed Luca Santarelli, M.D., as Chief Executive Officer and … highway sales inc lease trucksWebbför 2 dagar sedan · Therachon Holding AG is a privately held clinical-stage biotechnology company. Pfizer Inc. paid an additional USD 470 million for Therachon Holding AG, in … small texture packWebbFor instance, in July 2024, Pfizer Inc., a U.S.-based multinational pharmaceutical and biotechnology corporation, announced completion of its acquisition of Therachon … small textile business in pakistanWebb20 juni 2024 · Therachon is a global biotechnology company focused on developing medicines for rare, genetic diseases that currently have no available treatments. The company’s lead pipeline candidate, TA-46,... highway salt spreader storageWebbTHERACHON is a trademark and brand of THERACHON AG, PFIZER INC., Aeschenvorstadt 36, BASEL 4051, SWITZERLAND. This trademark was filed to EUIPO on Friday, January … small textured wall art